الفهرس 
Introduction And Aim Of WorkOnly 14 pages are availabe for public view
 |  | from | 118 |  |  |
| | | from | 118 | | |
Abstract
Background: Ischemic mitral regurgitation remains the subject of
much debate. The choice between therapeutic options is
characterized by the trade-off between reduced early operative
morbidity and mortality and avoidance of prosthetic valve related
complications with repair, versus a better long-term correction of
mitral insufficiency with replacement. Materials and Methods:
Between 2005 and 2007, 30 patients undergoing CABG for CAD,
with concomitant repair or replacement for their ischemic mitral
valve regurgitation are included in the study. Patients are followed
up for 2 years. Results: 21 patients had CABG + MVRp, 9 patients
had CABG + MVR. Early postoperative mortality was 11% for the
replacement group, and 5 % for the repair group. 2 years survival
was 78% for the replacement group, and 81% for the repair group.
Freedom from > 2+ MR was 76% for the repair group, and 100% for
the replacement group among survivors. Conclusion: MV repair
may be better in low-risk patients with ischemic mitral regurgitation.
Mitral valve replacement with intact subvalvular apparatus should be
considered in patients with chronic IMR who have multiple
comorbidities, complex regurgitant jets, or severe tethering of both
mitral valve leaflets.
Key words: ischemic- mitral regurgitation